Your browser doesn't support javascript.
loading
Management of Portal Hypertension.
Kulkarni, Anand V; Rabiee, Atoosa; Mohanty, Arpan.
Afiliación
  • Kulkarni AV; Department of Hepatology, AIG Hospitals, Hyderabad, India.
  • Rabiee A; VA Medical Center, Washington, DC, USA.
  • Mohanty A; Boston University School of Medicine, Boston, MA, USA.
J Clin Exp Hepatol ; 12(4): 1184-1199, 2022.
Article en En | MEDLINE | ID: mdl-35814519
ABSTRACT
Portal hypertension is the cause of the clinical complications associated with cirrhosis. The primary complications of portal hypertension are ascites, acute variceal bleed, and hepatic encephalopathy. Hepatic venous pressure gradient measurement remains the gold standard test for diagnosing cirrhosis-related portal hypertension. Hepatic venous pressure gradient more than 10 mmHg is associated with an increased risk of complications and is termed clinically significant portal hypertension (CSPH). Clinical, laboratory, and imaging methods can also aid in diagnosing CSPH non-invasively. Recently, deep learning methods have been demonstrated to diagnose CSPH effectively. The management of portal hypertension is always individualized and is dependent on the etiology, the availability of therapies, and the degree of portal hypertension complications. In this review, we discuss the diagnosis and management of cirrhosis-related portal hypertension in detail. Also, we highlight the history of portal hypertension and future research areas in portal hypertension.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Exp Hepatol Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Exp Hepatol Año: 2022 Tipo del documento: Article País de afiliación: India